Bisphosphonates pathway

Pharmacogenet Genomics. 2011 Jan;21(1):50-3. doi: 10.1097/FPC.0b013e328335729c.
No abstract available

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / pharmacokinetics
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use
  • Diphosphonates / adverse effects
  • Diphosphonates / pharmacokinetics
  • Diphosphonates / pharmacology*
  • Diphosphonates / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Models, Biological
  • Osteoporosis / drug therapy
  • Osteoporosis / genetics
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics

Substances

  • Bone Density Conservation Agents
  • Diphosphonates